Audio

Community Oncology Podcast - Abiraterone in metastatic prostate cancer

Publish date: August 31, 2012
By
Dr. David Henry

 

Editor-in-chief Dr. David H. Henry takes you on an audio tour of the August issue of Community Oncology featuring a Community Translation: Abiraterone boosts survival in metastatic prostate cancer and a review on maintenance therapy in solid tumors.

Recommended Reading

Prostate Cancer Insights From ASCO 2012
MDedge Hematology and Oncology
ASCO 2012: Radiotherapy for Locally Advanced Prostate Cancer
MDedge Hematology and Oncology
ASCO 2012: Radium-223 and Prostate Cancer Survival
MDedge Hematology and Oncology
Romidepsin-Decitabine Duo Battles Breast and Kidney Cancers
MDedge Hematology and Oncology
Enzalutamide Prolongs Prostate Cancer Survival After Chemotherapy Fails
MDedge Hematology and Oncology
Experimental Drug Improves Muscle Strength in Cancer
MDedge Hematology and Oncology
New Analysis Revises Benefits of PSA Screening Downward
MDedge Hematology and Oncology
Blood Test May Predict Temsirolimus Response in Kidney Cancer
MDedge Hematology and Oncology
Will They Still Give Strong to Lance Armstrong's Cancer Charity?
MDedge Hematology and Oncology
FDA Approves Enzalutamide for Prostate Cancer
MDedge Hematology and Oncology